BioMelbourne Network
Progressing BioIndustry

• Home
• About Us
• Events
• Grants & Awards
• News & Opinion
• Membership
• Resource Library
• Contact

Click here to view the supplement, published by Life Science CLUSTERS magazine.   read more…

Update on Seasonal Influenza Vaccination of Children Update on Seasonal Influenza Vaccination of Children Melbourne, Australia — 30/07/2010 CSL Limited (CSL) supports the statement made today by the Commonwealth Chief Medical Officer regarding seasonal flu vaccine for young children.Since becoming aware of an association between CSL’s influenza vaccine and increased febrile reactions in chil... read more…

Executive Director Resignation Management Appointment   Thursday 29th July 2010, Melbourne Australia: Halcygen Pharmaceuticals Limited today announced Executive Director and Chief Operating Officer Craig Bottomley would step down from the role after 5 years with the company due to family reasons.   Lisa Pendlebury would assume the role of Investor Relations Manager. Lisa was previously the... read more…

More than 300 jobs created as biotech giant expands 16 July 2010. Melbourne. The Victorian Government will back global biopharmaceutical company CSL to invest $235 million on a major expansion of its Broadmeadows facility which will create 333 new jobs by 2018. At CSL in Broadmeadows today, Premier John Brumby was joined by Commonwealth Minister for Innovation, Industry, Science and Research, S... read more…

14 July, 2010.  Innovation Minister, Senator Kim Carr, today announced over $2.2 million in support for eleven new projects. This follows the $9.6 million in funding announced in April. Unfortunately no Victorian companies were grant recipients.  To view the list of grant recipients, click here. read more…

AVEXA has gained 15% this morning after its new board elected former director Joe Baini as its new chairman and began preparing for an independent review of HIV drug apricitabine and discussions with regulatory authorities over ATC’s future potential. Baini retired from the board in May, a departure then-chairman Nathan Drona said was due to an “an inability to commit the require... read more…

Small technology means big business for Victoria   Self cleaning paint, miniature sensors that detect disease in its early stages and next generation batteries are all revolutionary products that could result from research undertaken at the new $57 million Melbourne Centre for Nanofabrication.     Opening the centre in Clayton today, Premier John Brumby and Innovation Minister Gavin Jenning... read more…

• Australian innovation already sold in US, Europe and Asia• Changes microbiology labs into automated workplaces 1 July 2010: Melbourne Pathology is the first Australian laboratory to acquire PREVI™ Isola.  Distributed by bioMérieux Australia Pty Ltd, PREVI™ Isola is based on LBT Innovations Limited (ASX: LBT) revolutionary MicroStreak® technology for automated agar plate streaking in microbio... read more…

Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International   28 June 2010. Philadelphia & London PRNewswire/ -- The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook compil... read more…

5 July 2010. The new Competitive Business Fund is a key component of Transition to a Global Future, a Victorian Government initiative to assist businesses to take maximum advantage of new opportunities that are emerging in the global economy. Funding in the order of $3.3 million is available in the first round of grants for projects that strengthen the competitiveness of strategic Victorian in... read more…